We are happy and proud to finally announce that CarboHyde won a 2024-1.2.7-EUROSTARS-2025-00007 grant and shall receive ~190,000k Eur to develop a novel cyclodextrin-based Alzheimer asset.
The novel mechanism of action focuses on cholesterol modulation in this neurodegenerative disease and will aim to complete most IND enabling preclinical studies so that regulatory filings and clinical studies can begin shortly.
Recently I had the chance to sit down with Louise Jefferies on her podcast Speaking up in English at Work for Introverts – and it turned into one of the most honest conversations I’ve had about science, communication, and the fears many of us quietly carry.
My main message was simple: Scientists are doing extraordinary work behind the scenes… but far too much of it never reaches the people who need it.
In the episode, we talked about something I see every day in our field: most scientists stay silent — not because they lack expertise, but because they doubt whether their voice matters. And that silence costs the industry more than we realise.
We unpacked a lot, including • why publishing papers is no longer enough • how misinformation fills the void when experts hold back • the visibility challenges introverts and multilingual scientists face • the fear of posting, presenting, or speaking up (and why our imagined catastrophes almost never happen) • why LinkedIn is actually one of the safest, kindest spaces to start sharing • and how having a purpose makes fear feel a lot smaller
If there’s one thing I hope listeners take away, it’s this: Your work can influence decisions, shape policy, and move our field forward — but only if your voice is heard.
You don’t need to be louder. You don’t need to perform. You just need to stop hiding expertise that genuinely matters.
If you’ve ever hesitated to post, present, or speak up in a meeting, this conversation might be exactly what you need.
Moga, Punjab, India – ISF College of Pharmacy (An Autonomous College), Moga, is proud to announce that it will host the 22nd International Cyclodextrin Symposium (ICS22) from October 22-26, 2026. This marks a historic milestone as the first time this prestigious international symposium is being held in India.
The symposium, themed “Integrating Cyclodextrin and AI Techniques for Next-Generation Novel Drug Delivery Systems,” will bring together more than 500 leading scientists, researchers, academicians, and industry professionals from over 40 countries to discuss groundbreaking advances in cyclodextrin chemistry and its revolutionary applications in pharmaceutical sciences.
The symposium will cover diverse topics including: # Cyclodextrin chemistry and characterization # Novel drug delivery systems # AI and machine learning in pharmaceutical formulation # Nanotechnology applications # Industrial perspectives and commercialization # Regulatory aspects and quality control # Clinical applications and case studies
Before Christmas, we presented the “exam” of the cyclodextrin masterclasses. The contestants competed online, facing 30 questions about cyclodextrins to find out who is the king of cyclodextrins.
Not only were the event and all the masterclasses fun to deliver, but Shima’s message also warmed our hearts dearly:
“I would like to sincerely thank you, for the excellent masterclasses and for all the support you provide. The sessions were extremely valuable and truly enhanced my understanding of cyclodextrins.
I also wanted to share that I placed first in the online competition . It was a great experience, and it would not have been possible without the quality of the training and materials you provided.
Thank you again for your dedication, knowledge sharing, and continuous support. It is greatly appreciated.”
Join us at the 2nd Bicyclos HEurope International School & Workshop (Feb 18–20, Seville) for expert seminars and hands-on training on cyclodextrin applications, AI-driven molecular design, IP, and scientific communication—tailored for PhD candidates, early postdocs, and industry R&I professionals.
Registration is mandatory and open until Jan 15, 2026—secure your spot to learn from leading experts, expand your network, and explore sustainable, next-generation approaches in cyclodextrin research.
?️ Dates
Feb 18–19: Expert seminars on cyclodextrin applications (from healthcare to environmental sciences)
Feb 19–20: Practical sessions on (i) research project preparation, (ii) AI for molecular design, data analysis & scientific writing, (iii) IP protection, and (iv) scientific communication & broadcasting
? Registration
Mandatory (Bicyclos registration form)
Free for Bicyclos staff
€200 for external participants (includes event access, lunches Feb 18–19, and coffee breaks Feb 18–20)
Deadline:Jan 15, 2026
Industry:exhibition space available on request
? Venue Institute of Chemical Research (IIQ, CSIC – University of Seville), well connected to the city center (bus/taxi).
? Accommodation tip Early booking recommended; Hotel Exe Macarena is suggested for convenient access and good value.
The School organised by CSIC, Sevilla, is aimed primarily at PhD candidates and early postdoctoral researchers, offering training on various aspects of cyclodextrin pharmacology, and biomedical applications, all within the broader context of sustainability.
In this context, advanced models in substitution of animal studies for drug development will be discussed. Scientific Masterclasses by external experts will be scheduled on the first two days. Extra classes in soft skills are planned on the third day. Check out the programme:
A key objective of the School is to foster networking opportunities among participants.
Moga, Punjab, India – ISF College of Pharmacy (An Autonomous College), Moga, is proud to announce that it will host the 22nd International Cyclodextrin Symposium (ICS22) from October 22-26, 2026. This marks a historic milestone as the first time this prestigious international symposium is being held in India.
The symposium, themed “Integrating Cyclodextrin and AI Techniques for Next-Generation Novel Drug Delivery Systems,” will bring together more than 500 leading scientists, researchers, academicians, and industry professionals from over 40 countries to discuss groundbreaking advances in cyclodextrin chemistry and its revolutionary applications in pharmaceutical sciences.
The symposium will cover diverse topics including: # Cyclodextrin chemistry and characterization # Novel drug delivery systems # AI and machine learning in pharmaceutical formulation # Nanotechnology applications # Industrial perspectives and commercialization # Regulatory aspects and quality control # Clinical applications and case studies
Last week, Kyoto hosted the 12th Asian Cyclodextrin Conference, bringing together researchers, collaborators, and long-time friends from around the world — including several members of Bicyclos HEurope.
For us at CarboHyde, the event felt like a reunion between the two main “homes” of cyclodextrin science. Japan has long been a cradle of CD innovation, while Hungary has become another strong home driving cyclodextrins toward new applications and industries. Seeing these two hubs reconnect in Kyoto was inspiring.
Our CSO, Milo Malanga, PhD, was also present — the smiling, chatty Italian in jeans who never misses the chance to ask a sharp question after each lecture. His presence helped spark new conversations and strengthen ongoing collaborations.
The conference offered what makes this community so special: solid science, meaningful dialogue, and friendships that push the field forward.
We return from Kyoto with renewed motivation — ready to turn last week’s ideas into future cyclodextrin innovations.
Not sure what is going on here, but Pedro Vieira most certainly exploits all the learning potential during his GlyCanDrug MSCA-DN secondment in Budapest.
First he learned about the fluorescent labelling of cyclodextrins with Milo and now he is trained by Balazs in formulating his insoluble sugars – again, with cyclodextrins.
